CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 60 enrolled
Drug / intervention
Resveratrol +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01640197
NCT01640197Phase 1Completed
CompareCT.gov

The Effects of Chronic Trans- Resveratrol Supplementation on Aspects of Cognitive Performance, Mood, Sleep, Health and Cerebral Blood Flow in Healthy, Young Humans.

Northumbria University·interventional·Posted Jul 13, 2012·Updated Oct 19, 2012

In Brief

A Phase 1 clinical trial evaluating Resveratrol and Placebo for Healthy. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited Kingdom
CollaboratorsBiotivia Longevity Bioceuticals

Timeline

Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 13, 2012
Enrollment StartFeb 1, 2011
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.0 years ago

Interventions

Resveratroldietary

Transmax (Biotivia). 500mg (1 capsule) per day for 28 days.

Placeboother

Methyl Cellulose. 1 capsule taken once daily for 28 days.